Reason | 6 Months (ART-naive), n = 45 | 6 Months (ART experienced), n = 85 | 12 Months (ART-naive), n = 8 | 12 Months (ART-experienced), n = 36 |
---|---|---|---|---|
Virologic failure | 1 | 3 | 0 | 0 |
Immunologic failure | 0 | 0 | 0 | 0 |
Clinical failure | 0 | 0 | 0 | 0 |
CNS adverse effects (grade 3–4) | 1 | 0 | 0 | 0 |
Renal toxicity (grade 3–4) | 1 | 3 | 0 | 0 |
Cost (change to nevirapine) | 0 | 1 | 1 | 0 |
Death | 0 | 0 | 0 | 1 |
Total | 3 | 7 | 1 | 1 |